Compile Data Set for Download or QSAR
maximum 50k data
Found 23 Enz. Inhib. hit(s) with all data for entry = 10317
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527731(US11186590, Compound 1-1)
Affinity DataEC50: <0.100nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527753(US11186590, Compound 3-19)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449002(2-[4-(4-aminopiperidin-1-yl)-2-(dimethylamino)-5-(...)
Affinity DataEC50: >1nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449003(US10696689, Compound 2-1 | US11186590, Compound 2-...)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449004(4-(4-aminopiperidin-1-yl)-3-(6-fluoro-4-methoxy-1H...)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449005(4-(4-aminopiperidin-1-yl)-3-(6-fluoro-4-methoxy-1H...)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527737(US11186590, Compound 3-1)
Affinity DataEC50: <0.100nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527738(US11186590, Compound 3-2)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527739(US11186590, Compound 3-3)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527740(US11186590, Compound 3-6)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527741(US11186590, Compound 3-7)
Affinity DataEC50: <0.100nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527742(US11186590, Compound 3-8)
Affinity DataEC50: <0.100nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527743(US11186590, Compound 3-9)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527744(US11186590, Compound 3-10)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527745(US11186590, Compound 3-11)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527746(US11186590, Compound 3-12)
Affinity DataEC50: >1nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527747(US11186590, Compound 3-13)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527748(US11186590, Compound 3-14)
Affinity DataEC50: <0.100nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527749(US11186590, Compound 3-15)
Affinity DataEC50: <0.100nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449019(2-{4-[(4αS,8αS)-octahydro-1H-pyrido[3,4-...)
Affinity DataEC50: <0.100nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527751(US11186590, Compound 3-17)
Affinity DataEC50: <0.100nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527752(US11186590, Compound 3-18)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM527732(US11186590, Compound 1-2)
Affinity DataEC50:  0.550nMAssay Description:Four days prior to the assay, 5,000 Chinese hamster ovary cells (CHO-K1, ATCC #CCL-61) stably expressing the human somatostatin receptor subtype 2 ar...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent